We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cutting-Edge Diagnostic Tool Rapidly Identifies Emerging SARS-CoV-2 Variants

By LabMedica International staff writers
Posted on 11 Nov 2024
Print article
Image: The molecular diagnostic tool, Intelli-OVI, offers the potential for continuous monitoring of emerging SARS-CoV-2 variants (Photo courtesy of Yorifumi Satou/Kumamoto University)
Image: The molecular diagnostic tool, Intelli-OVI, offers the potential for continuous monitoring of emerging SARS-CoV-2 variants (Photo courtesy of Yorifumi Satou/Kumamoto University)

As the COVID-19 pandemic continues to evolve, the emergence of new variants of the SARS-CoV-2 virus presents ongoing challenges for public health monitoring and response, despite the rise of vaccinations and herd immunity from previous infections, which have helped reduce severe cases compared to earlier in the pandemic. While traditional methods, such as whole-genome sequencing (WGS), offer high accuracy, they are time-consuming and costly. Researchers have now made a significant advancement in the battle against COVID-19 by developing an innovative diagnostic tool that can quickly identify emerging variants of the SARS-CoV-2 virus. This new system combines advanced DNA detection technology with sophisticated computational algorithms to provide a faster and more affordable method for monitoring viral mutations, a crucial tool for managing future pandemics.

A team of researchers from Kumamoto University (Kumamoto, Japan) developed the novel diagnostic tool, Intelli-OVI, which integrates IntelliPlex micro-disc technology with a groundbreaking algorithm called Objective Variant Identification (OVI). This system offers a faster alternative for detecting and distinguishing over 20 SARS-CoV-2 variants with high accuracy. IntelliPlex technology uses a microdisc that is printed with a unique pictorial pattern (πCode), enabling the system to capture and analyze specific genetic mutations in the virus. This process allows the system to simultaneously handle multiple viral mutations, greatly accelerating detection. The OVI algorithm then interprets the data to identify both known and new variants by analyzing the unique mutation patterns.

In laboratory tests, Intelli-OVI successfully identified over 20 variants, including several subtypes of the Omicron variant, using 35 different DNA probes. Unlike traditional PCR-based methods, which can only detect a limited number of mutations, Intelli-OVI has the theoretical capacity to analyze up to 100 viral mutation sites at once, making it one of the most comprehensive diagnostic tools available. The successful development of Intelli-OVI holds the potential to make a significant contribution to global pandemic preparedness. The research team envisions that this technology could be applied to other rapidly evolving viruses, offering an essential tool for early detection and containment strategies.

"Our system can be easily updated to track new viral mutations," said Professor Yorifumi Satou, the lead researcher from the Joint Research Center for Human Retrovirus Infection (JRCHRI), Kumamoto University. "This new diagnostic tool has the potential to revolutionize how we monitor viral mutations, not just for COVID-19, but for future pandemics as well.”

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0

Print article

Channels

Hematology

view channel
Image: Personalized blood count could lead to early intervention for common diseases (Photo courtesy of 123RF)

Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals

A complete blood count (CBC) screening is a standard examination most physicians request for healthy adults. This test is essential for evaluating a patient’s overall health with a single blood sample.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The BIOFIRE® FILMARRAY® Tropical Fever Panel has received U.S. FDA Special 510(k) clearance (Photo courtesy of bioMérieux)

Syndromic PCR Test Rapidly and Accurately Identifies Pathogens in Patients with Tropical Fever Infections

Tropical fevers refer to infections that are common in, or unique to, tropical and subtropical regions. As these diseases spread to previously unaffected areas and can be brought in by travelers, infections... Read more

Pathology

view channel
Image: The new study highlights efficiency in detecting infectious diseases (Photo courtesy of Adobe Stock)

Optimized Pooled Testing Approach Could Transform Public Health Screening for Infectious Diseases

Traditional individual testing methods can be resource-intensive, particularly when it comes to large-scale screenings. Pooled testing, on the other hand, enables the testing of multiple specimens together,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.